Handelsavisen
prelaunch
Companies Healthcare MAII.NS
MA
MAII.NS NSE (India) Healthcare Facilities & Services

Maii.Ns

$161,96
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-102,5 %
ROE
-39,1 %
Net margin
-96,5 %
Debt / equity
0,29
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

MAII.NS operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.

Business. MAII.NS operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-39,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning MAII.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to MAII.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    MAII.NS operates in the healthcare facilities and services industry, focusing on biotechnology, and generates revenue primarily through its services and products in this sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a debt-to-equity ratio of 0.29, indicating a relatively low level of leverage compared to industry norms. However, the company's liquidity position is assessed as medium, with a current ratio of 1.58, suggesting it has sufficient short-term assets to cover its short-term liabilities, but not in excess. The company's cash and equivalents amount to INR 157.7 million, which is significantly lower than its long-term debt of INR 1.023 billion, indicating a potential liquidity constraint.

    Profitability metrics reveal a challenging financial position for the company. The return on equity is -0.3914, and the return on assets is -0.2218, both of which are negative and significantly below the industry median. This indicates that the company is not generating returns that meet the expectations of its equity and asset base. The operating income is negative at INR -1.491 billion, and the net income is also negative at INR -1.404 billion, further highlighting the company's unprofitable operations.

    The company's revenue is concentrated in a single segment, as disclosed in its financial statements, with no significant geographic diversification reported. This concentration increases the risk associated with the company's revenue streams, as it is heavily dependent on a single business line. The lack of geographic diversification also limits the company's ability to mitigate risks associated with regional economic downturns or regulatory changes.

    The company's growth trajectory is currently negative, with a significant decline in revenue and profitability. The operating cash flow is negative at INR -1.276 billion, and the free cash flow is also negative at INR -1.583 billion, indicating that the company is not generating sufficient cash to fund its operations and capital expenditures. The capital expenditure of INR -358.78 million further exacerbates the company's cash flow challenges.

    The risk assessment indicates a medium liquidity risk, primarily due to the company's negative net cash position after accounting for total debt. The dilution risk is assessed as low, suggesting that the company is not expected to issue additional shares in the near term to raise capital. However, the company's negative operating and net income, along with its high debt levels, may necessitate future capital raising activities, which could lead to dilution.

    Recent events, as disclosed in the company's financial filings, indicate a continued focus on cost management and operational efficiency. The company has not reported any significant new product launches or strategic acquisitions in the recent period, which may impact its ability to drive future growth. The company's management has also not provided any forward-looking guidance that suggests a turnaround in its financial performance.

    Key takeaways
    • The company is currently unprofitable, with negative operating and net income.
    • The company's liquidity position is medium, with a current ratio of 1.58.
    • The company's return on equity and return on assets are significantly below industry medians.
    • The company's revenue is concentrated in a single segment, increasing its risk exposure.
    • The company's growth trajectory is negative, with declining revenue and profitability.
    • The company's capital structure is relatively low in leverage, but its negative cash flow and high debt levels pose liquidity risks.
    • **margin_outlook_rationale**: The company's margin outlook is negative due to its declining profitability and high operating costs.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $161,96
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $3.59B
    Net cash
    -$865.3M
    Current ratio
    1.6
    Debt / equity
    0.3
    ROA
    -22.2%
    ROE
    -39.1%
    Cash conversion
    91.0%
    CapEx / revenue
    -24.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-102,5 %Bottom quartile
    Net Margin-96,5 %Bottom quartile
    ROE-39,1 %Bottom quartile
    Capex / Rev-24,7 %Bottom quartile
    D/E0,29Above median
    Cash Conv0,91Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • MAII.NS Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    MAII.NSCanonical
    NSE (India) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage